Véronique Leblond
Véronique Leblond, MD, is a professor of hematology and the head of the Department of Hematology at Pitié-Salpêtrière Hospital in Paris, France. She is the chair of the French Innovative Leukemia Organization, which is involved in acute leukemia, chronic lymphocytic leukemia (CLL), and Waldenström’s macroglobulinemia (WM), including more than 90 centers in France.
Clinical focus and interest:
Professor Leblond is responsible for a rare tumor network (K-VIROGREF) dedicated to the management of transplant recipients with virus-induced tumors and funded by the French National Cancer Institute in 2012. The team historically focuses more specifically on chronic B-cell lymphoproliferative disorders (CLL and WM); amyloidosis; ocular and CNS lymphoma; and lymphoproliferation in immunosuppressed patients (patients with HIV and patients who have received organ transplants). She is an author of over 360 research articles, books, and book chapters.
Experience:
Professor Leblond earned her MD from the University of Medicine of Paris in 1983 and a research diploma in human biology (specializing in hematology) in 1987. In 1996, she was awarded a professorship of hematology at the University of Medicine Paris VI.
Affiliations:
Professor Leblond is a member of the French Society of Hematology and ASH, and has been the principal investigator of biological and clinical trials in CLL and WM. She received the Robert Kyle award in 2008 and the Waldenström Award in 2012. Professor Leblond is connected to several very active patient associations and charities: Laurette Fugain, SILLC, the International Waldenstrom’s Macroglobulinemia Foundation, and Waldenström France.